Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
eli lilly
4
×
life sciences
national blog main
san francisco blog main
biotech
clinical trials
new york blog main
new york top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
fda
fremanezumab
indiana blog main
indiana top stories
migraine
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
What
companies
4
×
new
4
×
drug
approval
bio
cancer
medicines
arguments
bets
big
biogen’s
biopharmaceutical
biotech
black
class
clinic
comes
commercialized
competitors
convo
cut
date
deal
decades
diamond
drugs
earlier
effective
eluded
enticed
evidence
failures
fda
hasn’t
hopes
ipo
latest
lead
leading
lines
Language
unset
Current search:
companies
×
new
×
" eli lilly "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines